Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Hisse Senetlerindeki Sıralama #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Hisse Fiyatı
$419.17
Piyasa Değeri
$333.66B
Değişim (1 gün)
0.50%
Değişim (1 yıl)
21.90%
Ülke
CH
Ticaret Roche Holding AG (ROG)

Kategori

Roche Holding AG (ROG) için kazanç
Dec 2025 itibarıyla kazanç TTM: $21.39B
Roche Holding AG şirketinin en son finansal raporlarına göre, mevcut kazancı $21.39B'dir. 2019 yılında şirket $17.17B kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Roche Holding AG için kazanç geçmişi 2019 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $21.39B 12.07%
2021 $19.09B 11.13%
2019 $17.17B 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke